The store will not work correctly when cookies are disabled.
5-tert-butyl-N-(3-hydroxyphenyl)-2-pyrazinecarboxamide
ID: ALA2288607
PubChem CID: 76331126
Max Phase: Preclinical
Molecular Formula: C15H17N3O2
Molecular Weight: 271.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1cnc(C(=O)Nc2cccc(O)c2)cn1
Standard InChI: InChI=1S/C15H17N3O2/c1-15(2,3)13-9-16-12(8-17-13)14(20)18-10-5-4-6-11(19)7-10/h4-9,19H,1-3H3,(H,18,20)
Standard InChI Key: NPTDZPNKARLYAX-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
25.7444 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3316 -26.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3316 -24.6525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5103 -26.0761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1017 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5103 -24.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5657 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9743 -26.0761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9743 -24.6525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7956 -24.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2083 -23.9406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0296 -23.9406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4382 -24.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0296 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2083 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4382 -23.2288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.2804 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8677 -26.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4591 -25.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8677 -24.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
2 4 2 0
4 5 1 0
5 6 2 0
3 6 1 0
7 8 2 0
7 9 1 0
1 7 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
12 16 1 0
9 10 1 0
17 18 1 0
17 20 1 0
17 19 1 0
5 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.32 | Molecular Weight (Monoisotopic): 271.1321 | AlogP: 2.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.11 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.23 | CX Basic pKa: ┄ | CX LogP: 2.64 | CX LogD: 2.64 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -1.23 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |